advertisement
Yoshikawa K 12
Showing records 1 to 12 | Display all abstracts from Yoshikawa K69466 Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
Naito T
Clinical Ophthalmology 2016; 10: 1397-1403
69287 Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells
Nakano T; Inoue R
Advances in Therapy 2016; 33: 1452-1459
69466 Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
Yoshikawa K
Clinical Ophthalmology 2016; 10: 1397-1403
69287 Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells
Kimura T
Advances in Therapy 2016; 33: 1452-1459
69466 Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
Mizoue S
Clinical Ophthalmology 2016; 10: 1397-1403
69287 Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells
Suzumura H
Advances in Therapy 2016; 33: 1452-1459
69466 Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
Nanno M; Kimura T
Clinical Ophthalmology 2016; 10: 1397-1403
69287 Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells
Tanino T
Advances in Therapy 2016; 33: 1452-1459
69466 Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
Suzumura H
Clinical Ophthalmology 2016; 10: 1397-1403
69287 Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells
Yamazaki Y; Yoshikawa K
Advances in Therapy 2016; 33: 1452-1459
69466 Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
Umeda Y; Shiraga F
Clinical Ophthalmology 2016; 10: 1397-1403
69287 Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells
Tatemichi M
Advances in Therapy 2016; 33: 1452-1459
